Charpentier, Emmanuelle

Publication with MATCHING institution:

Alagesan K, Charpentier E (2023) Systems-Wide Site-Specific Analysis of Glycoproteins. Methods in Molecular Biology.
[IF=0.413, Cited=0, 37665459].
Gálvez EJC, Iljazovic A, Amend L, ..., Strowig T (2020) Distinct Polysaccharide Utilization Determines Interspecies
Competition between Intestinal Prevotella spp. None. [IF=None, Cited=48, 33113351].
Ratner HK, Escalera-Maurer A, Le Rhun A, ..., Weiss DS (2019) Catalytically Active Cas9 Mediates Transcriptional
Interference to Facilitate Bacterial Virulence. Molecular Cell. [IF=2.773, Cited=32, 31256988].
Birk MS, Charpentier E, Frese CK (2021) Automated Phosphopeptide Enrichment for Gram-Positive Bacteria. Journal of
Proteome Research. [IF=0.952, Cited=5, 34473931].
Broglia L, Lécrivain AL, Renault TT, ..., Charpentier E (2020) An RNA-seq based comparative approach reveals the
transcriptome-wide interplay between 3'-to-5' exoRNases and RNase Y. Nature Communications. [IF=3.268, Cited=19, 32221293].
Hüsing S, Halte M, van Look U, ..., Renault TT (2021) Control of membrane barrier during bacterial type-III protein
secretion. Nature Communications. [IF=3.268, Cited=10, 34183670].
Makarova K, Makarova KS, Wolf YI, ..., Koonin EV (2019) Evolutionary classification of CRISPR-Cas systems: a burst of
class 2 and derived variants. Nature Reviews Microbiology. [IF=6.979, Cited=809, 31857715].
Bratovič M, Fonfara I, Chylinski K, ..., Charpentier E (2020) Bridge helix arginines play a critical role in Cas9
sensitivity to mismatches. Nature Chemical Biology. [IF=2.623, Cited=28, 32123387].
Naseri G, Raasch H, Charpentier E, Erhardt M (2023) A versatile regulatory toolkit of arabinose-inducible artificial
transcription factors for Enterobacteriaceae. Communications Biology. [IF=1.359, Cited=0, 37789111].
Lécrivain AL, Le Rhun A, Renault TT, ..., Charpentier E (2018) In vivo 3'-to-5' exoribonuclease targetomes of
Streptococcus pyogenes. Proceedings of the National Academy of Sciences of the United States of America.
[IF=2.765, Cited=16, 30381461].
Broglia L, Materne S, Lécrivain AL, ..., Charpentier E (2018) RNase Y-mediated regulation of the streptococcal pyrogenic
exotoxin B. RNA Biology. [IF=0.745, Cited=7, 30290721].
Le Rhun A, Escalera-Maurer A, Bratovič M, Charpentier E (2019) CRISPR-Cas in Streptococcus pyogenes. RNA Biology.
[IF=0.745, Cited=46, 30856357].
Charpentier E, Elsholz A, Marchfelder A (2019) CRISPR-Cas: more than ten years and still full of mysteries. RNA Biology.
[IF=0.745, Cited=2, 31009325].
Righetti F, Materne SL, Boss J, ..., Loh E (2020) Characterization of a transcriptional TPP riboswitch in the human
pathogen Neisseria meningitidis. RNA Biology. [IF=0.745, Cited=3, 32079473].
Broglia L, Le Rhun A, Charpentier E (2023) Methodologies for bacterial ribonuclease characterization using RNA-seq. FEMS
Microbiology Reviews. [IF=2.966, Cited=1, 37656885].
Wulff TF, Hahnke K, Lécrivain AL, ..., Charpentier E (2024) Dynamics of diversified A-to-I editing in Streptococcus
pyogenes is governed by changes in mRNA stability. Nucleic Acids Research. [IF=4.663, Cited=0, 39087550].
Birk MS, Ahmed-Begrich R, Tran S, ..., Charpentier E (2021) Time-Resolved Proteome Analysis of Listeria
monocytogenes during Infection Reveals the Role of the AAA+ Chaperone ClpC for Host Cell Adaptation. mSystems.
[IF=1.193, Cited=4, 34342529].
Muñoz-Gutierrez V, Cornejo FA, Schmidt K, ..., Charpentier E (2024) Bacillus subtilis remains translationally
active after CRISPRi-mediated replication initiation arrest. mSystems. [IF=1.193, Cited=0, 38546227].
Lautenschläger N, Schmidt K, Schiffer C, ..., Charpentier E (2024) Expanding the genetic toolbox for the obligate human
pathogen Streptococcus pyogenes. Frontiers in Bioengineering and Biotechnology. [IF=1.212, Cited=0, 38911550].
Beerens D, Franch-Arroyo S, Sullivan TJ, ..., Charpentier E (2021) Survival Strategies of Streptococcus pyogenes
in Response to Phage Infection. Viruses. [IF=1.071, Cited=5, 33918348].

Publication with MISMATCHING institution:

Charpentier E, Gerbaud G, Courvalin P (1993) Characterization of a new class of tetracycline-resistance gene tet(S) in
Listeria monocytogenes BM4210. Gene. [IF=0.932, Cited=59, 8370538].
Charpentier E, Barna A, Guillevin L, Juliard JM (2015) Fully bioresorbable drug-eluting coronary scaffolds: A review.
Archives of Cardiovascular Diseases. [IF=0.855, Cited=15, 26113479].
Taron-Brocard C, Looten V, Fahlgren B, ..., Barna A (2016) [Congestive heart failure: Treatment with ultrafiltration].
Annales de Cardiologie et d'Angeiologie. [IF=0.24, Cited=1, 27344095].
Labenski V, Suerth JD, Barczak E, ..., Schambach A (2016) Alpharetroviral self-inactivating vectors produced by a
superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes.
Biomaterials. [IF=1.871, Cited=11, 27162078].
Hille F, Richter H, Wong SP, ..., Charpentier E (2018) The Biology of CRISPR-Cas: Backward and Forward. Cell. [IF=8.479,
Cited=392, 29522745].
Salsé M, Gangneux JP, Cassaing S, ..., Sasso M (2019) Multicentre study to determine the Etest epidemiological cut-off
values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex. Clinical Microbiology and
Infection. [IF=2.827, Cited=17, 31082487].
Charpentier E, Benichou E, Pagès A, ..., Iriart X (2019) Performance evaluation of different strategies based on
microscopy techniques, rapid diagnostic test and molecular loop-mediated isothermal amplification assay for the
diagnosis of imported malaria. Clinical Microbiology and Infection. [IF=2.827, Cited=26, 31158521].
Richter F, Fonfara I, Gelfert R, ..., Möglich A (2017) Switchable Cas9. Current Opinion in Biotechnology. [IF=1.815,
Cited=22, 28456061].
Colin M, Charpentier E, Klingelschmitt F, ..., Gangloff SC (2019) Specific antibacterial activity of copper alloy touch
surfaces in five long-term care facilities for older adults. Journal of Hospital Infection. [IF=1.624, Cited=7, 31809775].
Bane K, Charpentier E, Bronnec F, ..., Azérad J (2015) Randomized Clinical Trial of Intraosseous Methylprednisolone
Injection for Acute Pulpitis Pain. Journal of Endodontics. [IF=1.796, Cited=4, 26603771].
Vaquero-Herrero MP, Ragozzino S, Iriart X, ..., Ternavasio-de la Vega HG (2020) Candida bloodstream infection in
patients with systemic autoimmune diseases. None. [IF=None, Cited=3, 32113868].
Charpentier E, Marraffini LA (2014) Harnessing CRISPR-Cas9 immunity for genetic engineering. Current Opinion in
Microbiology. [IF=1.52, Cited=43, 25048165].
Heckl D, Charpentier E (2015) Toward Whole-Transcriptome Editing with CRISPR-Cas9. Molecular Cell. [IF=2.773, Cited=9, 26000839].
Sternberg SH, Richter H, Charpentier E, Qimron U (2016) Adaptation in CRISPR-Cas Systems. Molecular Cell. [IF=2.773,
Cited=122, 26949040].
Desbois AC, Charpentier E, Chapelon C, ..., Saadoun D (2022) [Cardiac sarcoidosis: Diagnosis, prognosis and
therapeutics]. None. [IF=None, Cited=0, 35315339].
Tsatsaronis JA, Franch-Arroyo S, Resch U, Charpentier E (2018) Extracellular Vesicle RNA: A Universal Mediator of
Microbial Communication? Trends in Microbiology. [IF=3.2, Cited=100, 29548832].
Charpentier E, Danchin N, Edlinger C, ..., Fery-Lemonnier E (2003) [Intracoronary brachytherapy: a meta-analysis].
Annales de Cardiologie et d'Angeiologie. [IF=0.24, Cited=0, 12938568].
Charpentier E, Tuomanen E (2000) Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes
and Infection. [IF=0.971, Cited=36, 11165930].
Fonfara I, Richter H, Bratovič M, ..., Charpentier E (2016) The CRISPR-associated DNA-cleaving enzyme Cpf1 also
processes precursor CRISPR RNA. Nature. [IF=11.591, Cited=401, 27096362].
Bosley KS, Botchan M, Bredenoord AL, ..., Zhou Q (2015) CRISPR germline engineering--the community speaks. Nature
Biotechnology. [IF=8.861, Cited=54, 25965754].
Makarova K, Makarova KS, Wolf YI, ..., Koonin EV (2015) An updated evolutionary classification of CRISPR-Cas systems.
Nature Reviews Microbiology. [IF=6.979, Cited=1000, 26411297].
Eggenschwiler R, Moslem M, Fráguas MS, ..., Cantz T (2016) Improved bi-allelic modification of a transcriptionally
silent locus in patient-derived iPSC by Cas9 nickase. Scientific Reports. [IF=1.312, Cited=19, 27910942].
Dumas M, Fay AF, Charpentier E, Matricon J (2023) [Digital twins in healthcare: State of the art and potential use cases
in a hospital setting]. Medecine/Sciences. [IF=0.164, Cited=0, 38108726].
Le Rhun A, Beer YY, Reimegård J, ..., Charpentier E (2016) RNA sequencing uncovers antisense RNAs and novel small RNAs
in Streptococcus pyogenes. RNA Biology. [IF=0.745, Cited=16, 26580233].
Charpentier E, Lavker RM, Acquista E, Cowin P (2000) Plakoglobin suppresses epithelial proliferation and hair growth in
vivo. Journal of Cell Biology. [IF=1.509, Cited=75, 10769039].
Hurwitz JL, Jones BG, Charpentier E, Woodland DL (2017) Hypothesis: RNA and DNA Viral Sequence Integration into the
Mammalian Host Genome Supports Long-Term B Cell and T Cell Adaptive Immunity. Viral Immunology. [IF=0.535, Cited=4, 29028182].
Charpentier E (2018) Spotlight on… Emmanuelle Charpentier. FEMS Microbiology Letters. [IF=0.605, Cited=0, 29390135].
Plagens A, Richter H, Charpentier E, Randau L (2015) DNA and RNA interference mechanisms by CRISPR-Cas surveillance
complexes. FEMS Microbiology Reviews. [IF=2.966, Cited=66, 25934119].
Charpentier E, Richter H, van der Oost J, White MF (2015) Biogenesis pathways of RNA guides in archaeal and bacterial
CRISPR-Cas adaptive immunity. FEMS Microbiology Reviews. [IF=2.966, Cited=136, 25994611].
Charpentier E, Gerbaud G, Jacquet C, ..., Courvalin P (1995) Incidence of antibiotic resistance in Listeria species.
Journal of Infectious Diseases. [IF=1.292, Cited=76, 7797931].
Fonfara I, Le Rhun A, Chylinski K, ..., Charpentier E (2013) Phylogeny of Cas9 determines functional exchangeability of
dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Research. [IF=4.663, Cited=200, 24270795].
Chylinski K, Makarova K, Makarova KS, ..., Koonin EV (2014) Classification and evolution of type II CRISPR-Cas systems.
Nucleic Acids Research. [IF=4.663, Cited=231, 24728998].
Le Rhun A, Lécrivain AL, Reimegård J, ..., Charpentier E (2017) Identification of endoribonuclease specific cleavage
positions reveals novel targets of RNase III in Streptococcus pyogenes. Nucleic Acids Research. [IF=4.663, Cited=15, 28082390].
Richter F, Fonfara I, Bouazza B, ..., Möglich A (2016) Engineering of temperature- and light-switchable Cas9 variants.
Nucleic Acids Research. [IF=4.663, Cited=56, 27744350].
Labuhn M, Adams FF, Ng M, ..., Heckl D (2018) Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-
Cas9 applications. Nucleic Acids Research. [IF=4.663, Cited=127, 29267886].
Hille F, Charpentier E (2016) CRISPR-Cas: biology, mechanisms and relevance. Philosophical Transactions of the Royal
Society B: Biological Sciences. [IF=1.629, Cited=138, 27672148].
Bürkner PC, Charpentier E (2020) Modelling monotonic effects of ordinal predictors in Bayesian regression models.
British Journal of Mathematical and Statistical Psychology. [IF=1.883, Cited=29, 31943157].
Latvala S, Mäkelä SM, Miettinen M, ..., Julkunen I (2014) Dynamin inhibition interferes with inflammasome activation and
cytokine gene expression in Streptococcus pyogenes-infected human macrophages. Clinical and Experimental Immunology.
[IF=1.013, Cited=6, 25079511].
Simon S, Perard M, Zanini M, ..., Lumley PJ (2012) Should pulp chamber pulpotomy be seen as a permanent treatment? Some
preliminary thoughts. International Endodontic Journal. [IF=2.144, Cited=45, 22900881].
Fuhrmann J, Schmidt A, Spiess S, ..., Clausen T (2009) McsB is a protein arginine kinase that phosphorylates and
inhibits the heat-shock regulator CtsR. Science. [IF=7.729, Cited=92, 19498169].
Jinek M, Chylinski K, Fonfara I, ..., Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive
bacterial immunity. Science. [IF=7.729, Cited=1000, 22745249].
Jinek M, Jiang F, Taylor DW, ..., Doudna JA (2014) Structures of Cas9 endonucleases reveal RNA-mediated conformational
activation. Science. [IF=7.729, Cited=573, 24505130].
Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science.
[IF=7.729, Cited=1000, 25430774].
Charpentier E, Gerbaud G, Courvalin P (1994) Presence of the Listeria tetracycline resistance gene tet(S) in
Enterococcus faecalis. Antimicrobial Agents and Chemotherapy. [IF=1.175, Cited=36, 7840565].
Charpentier E, Courvalin P (1997) Emergence of the trimethoprim resistance gene dfrD in Listeria monocytogenes BM4293.
Antimicrobial Agents and Chemotherapy. [IF=1.175, Cited=39, 9145882].
Charpentier E, Courvalin P (1999) Antibiotic resistance in Listeria spp. Antimicrobial Agents and Chemotherapy.
[IF=1.175, Cited=136, 10471548].
Charpentier E, Anton AI, Barry P, ..., Novick RP (2004) Novel cassette-based shuttle vector system for gram-positive
bacteria. Applied and Environmental Microbiology. [IF=1.103, Cited=287, 15466553].
Charpentier E, Gerbaud G, Courvalin P (1999) Conjugative mobilization of the rolling-circle plasmid pIP823 from Listeria
monocytogenes BM4293 among gram-positive and gram-negative bacteria. Journal of Bacteriology. [IF=0.898, Cited=37, 10348847].
Novak R, Cauwels A, Charpentier E, Tuomanen E (1999) Identification of a Streptococcus pneumoniae gene locus encoding
proteins of an ABC phosphate transporter and a two-component regulatory system. Journal of Bacteriology. [IF=0.898,
Cited=52, 9973337].
Garnier F, Janapatla RP, Charpentier E, ..., Ploy MC (2007) Insertion sequence 1515 in the ply gene of a type 1 clinical
isolate of Streptococcus pneumoniae abolishes pneumolysin expression. Journal of Clinical Microbiology. [IF=1.711,
Cited=7, 17494718].
Resch U, Tsatsaronis JA, Le Rhun A, ..., Charpentier E (2016) A Two-Component Regulatory System Impacts Extracellular
Membrane-Derived Vesicle Production in Group A Streptococcus. mBio. [IF=1.357, Cited=81, 27803183].
Charpentier E, Looten V, Fahlgren B, ..., Guillevin L (2016) Meta-analytic estimation of measurement variability and
assessment of its impact on decision-making: the case of perioperative haemoglobin concentration monitoring. BMC Medical
Research Methodology. [IF=2.055, Cited=4, 26787309].
Augy JL, Aissaoui N, Richard C, ..., Diehl JL (2019) A 2-year multicenter, observational, prospective, cohort study on
extracorporeal CO₂ removal in a large metropolis area. Journal of Intensive Care. [IF=1.652, Cited=11, 31452899].
Fabiani FD, Renault TT, Peters B, ..., Erhardt M (2017) A flagellum-specific chaperone facilitates assembly of the core
type III export apparatus of the bacterial flagellum. PLoS Biology. [IF=2.285, Cited=31, 28771474].
Thevenard J, Verzeaux L, Devy J, ..., Emonard H (2014) Low-density lipoprotein receptor-related protein-1 mediates
endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities. PLoS ONE.
[IF=1.253, Cited=24, 25075518].
Charpentier E (2015) CRISPR-Cas9: how research on a bacterial RNA-guided mechanism opened new perspectives in
biotechnology and biomedicine. EMBO Molecular Medicine. [IF=1.957, Cited=15, 25796552].
Reimer J, Knöß S, Labuhn M, ..., Heckl D (2017) CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in
human hematopoietic progenitor cells in vivo. Haematologica. [IF=1.843, Cited=43, 28572162].
Elsholz AKW, Birk MS, Charpentier E, Turgay K (2017) Functional Diversity of AAA+ Protease Complexes in Bacillus
subtilis. Frontiers in Molecular Biosciences. [IF=0.92, Cited=23, 28748186].
Renault TT, Abraham AO, Bergmiller T, ..., Erhardt M (2017) Bacterial flagella grow through an injection-diffusion
mechanism. eLife. [IF=1.743, Cited=39, 28262091].

Publication with MISSING institution:

Romby P, Charpentier E (2009) An overview of RNAs with regulatory functions in gram-positive bacteria. Cellular and
Molecular Life Sciences. [IF=1.825, Cited=69, 19859665].
Devy J, Ouchani F, Oudot C, ..., Charpentier E (2010) The anti-invasive activity of synthetic alkaloid ethoxyfagaronine
on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.
Investigational New Drugs. [IF=0.78, Cited=4, 20349265].
Ouchani F, Jeanne A, Thevenard J, ..., Devy J (2014) Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits
vascular endothelial growth factor-1, as a new anti-angiogeneic agent. Investigational New Drugs. [IF=0.78, Cited=3, 25404487].
El Btaouri H, Morjani H, Greffe Y, ..., Martiny L (2011) Role of JNK/ATF-2 pathway in inhibition of thrombospondin-1
(TSP-1) expression and apoptosis mediated by doxorubicin and camptothecin in FTC-133 cells. None. [IF=None, Cited=11, 21333695].
Lescaille G, Coudert AE, Baaroun V, ..., Descroix V (2013) Clinical study evaluating the effect of bevacizumab on the
severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients. None. [IF=None, Cited=25, 24120382].
Fuhrmann J, Mierzwa B, Trentini DB, ..., Clausen T (2013) Structural basis for recognizing phosphoarginine and evolving
residue-specific protein phosphatases in gram-positive bacteria. Cell Reports. [IF=1.738, Cited=30, 23770242].
Cech TR, Charpentier E, Ciechanover A, ..., Wüthrich K (2024) Reflections from Nobel laureates in chemistry. Cell
Chemical Biology. [IF=1.446, Cited=0, 39151404].
Bridoux L, Etique N, Lambert E, ..., Charpentier E (2013) A crucial role for Lyn in TIMP-1 erythroid cell survival
signalling pathway. FEBS Letters. [IF=0.871, Cited=8, 23583449].
Lassaire J, Costi A, Charpentier E, Castro M (2012) Post-orthodontic intra- and interarch changes at 1 year: a
retrospective study assessing the impact of anterior fixed retention. None. [IF=None, Cited=1, 22516027].
Fineran PC, Charpentier E (2012) Memory of viral infections by CRISPR-Cas adaptive immune systems: acquisition of new
information. Virology. [IF=0.835, Cited=126, 23123013].
Marciano J, Michailesco P, Charpentier E, ..., Abadie MJ (1992) Thermomechanical analysis of dental gutta-percha.
Journal of Endodontics. [IF=1.796, Cited=11, 1402583].
Novak R, Charpentier E, Braun JS, Tuomanen E (2000) Signal transduction by a death signal peptide: uncovering the
mechanism of bacterial killing by penicillin. Molecular Cell. [IF=2.773, Cited=51, 10678168].
Hukic M, Hübschen JM, Seremet M, ..., Muller CP (2011) An outbreak of rubella in the Federation of Bosnia and
Herzegovina between December 2009 and May 2010 indicates failure to vaccinate during wartime (1992-1995). Epidemiology
and Infection. [IF=1.015, Cited=3, 21524344].
Novak R, Henriques B, Charpentier E, ..., Tuomanen E (1999) Emergence of vancomycin tolerance in Streptococcus
pneumoniae. Nature. [IF=11.591, Cited=184, 10376600].
Charpentier E, Doudna JA (2013) Biotechnology: Rewriting a genome. Nature. [IF=11.591, Cited=102, 23467164].
Lander E, Lander ES, Baylis F, ..., Winnacker EL (2019) Adopt a moratorium on heritable genome editing. Nature.
[IF=11.591, Cited=99, 30867611].
Deltcheva E, Chylinski K, Sharma CM, ..., Charpentier E (2011) CRISPR RNA maturation by trans-encoded small RNA and host
factor RNase III. Nature. [IF=11.591, Cited=1000, 21455174].
Makarova K, Makarova KS, Haft DH, ..., Koonin EV (2011) Evolution and classification of the CRISPR-Cas systems. Nature
Reviews Microbiology. [IF=6.979, Cited=1000, 21552286].
Novak R, Braun JS, Charpentier E, Tuomanen E (1998) Penicillin tolerance genes of Streptococcus pneumoniae: the ABC-type
manganese permease complex Psa. Molecular Microbiology. [IF=1.094, Cited=77, 9767595].
Novak R, Charpentier E, Braun JS, ..., Masure R (2000) Extracellular targeting of choline-binding proteins in
Streptococcus pneumoniae by a zinc metalloprotease. Molecular Microbiology. [IF=1.094, Cited=32, 10792723].
Novak R, Tuomanen E, Charpentier E (2000) The mystery of psaA and penicillin tolerance in Streptococcus pneumoniae.
Molecular Microbiology. [IF=1.094, Cited=7, 10947276].
Charpentier E, Novak R, Tuomanen E (2000) Regulation of growth inhibition at high temperature, autolysis, transformation
and adherence in Streptococcus pneumoniae by clpC. Molecular Microbiology. [IF=1.094, Cited=38, 10972795].
Gratz N, Siller M, Schaljo B, ..., Kovarik P (2008) Group A streptococcus activates type I interferon production and
MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9. Journal of Biological Chemistry. [IF=1.122,
Cited=60, 18480050].
Schmitz FJ, Beyer A, Charpentier E, ..., Novak R (2003) Toxin-gene profile heterogeneity among endemic invasive European
group A streptococcal isolates. Journal of Infectious Diseases. [IF=1.292, Cited=66, 14624385].
Vojtek I, Pirzada ZA, Henriques-Normark B, ..., Charpentier E (2008) Lysogenic transfer of group A Streptococcus
superantigen gene among Streptococci. Journal of Infectious Diseases. [IF=1.292, Cited=18, 18179387].
Davies K, Charpentier E (2019) Finding Her Niche: An Interview with Emmanuelle Charpentier. CRISPR Journal. [IF=0.697,
Cited=0, 31021229].
Delahaye N, Crestani B, Rakotonirina H, ..., Le Guludec D (2003) Comparative impact of standard approach, FDG PET and
FDG dual-head coincidence gamma camera imaging in preoperative staging of patients with non-small-cell lung cancer.
Nuclear Medicine Communications. [IF=0.623, Cited=2, 14627847].
Halte M, Popp PF, Hathcock D, ..., Renault TT (2024) Bacterial motility depends on a critical flagellum length and
energy-optimised assembly. None. [IF=None, Cited=0, 38979141].
Mangold M, Siller M, Roppenser B, ..., Charpentier E (2004) Synthesis of group A streptococcal virulence factors is
controlled by a regulatory RNA molecule. Molecular Microbiology. [IF=1.094, Cited=77, 15387826].
Hübschen JM, Mbah PO, Forbi JC, ..., Muller CP (2011) Detection of a new subgenotype of hepatitis B virus genotype A in
Cameroon but not in neighbouring Nigeria. Clinical Microbiology and Infection. [IF=2.827, Cited=28, 20219082].
Siller M, Janapatla RP, Pirzada ZA, ..., Charpentier E (2008) Functional analysis of the group A streptococcal luxS/AI-2
system in metabolism, adaptation to stress and interaction with host cells. BMC Microbiology. [IF=1.131, Cited=26, 18973658].
Schikora A, Carreri A, Charpentier E, Hirt H (2008) The dark side of the salad: Salmonella typhimurium overcomes the
innate immune response of Arabidopsis thaliana and shows an endopathogenic lifestyle. PLoS ONE. [IF=1.253, Cited=79, 18509467].
Ouchani F, Devy J, Rusciani A, ..., Charpentier E (2012) Targeting focal adhesion assembly by ethoxyfagaronine prevents
lymphoblastic cell adhesion to fibronectin. Analytical Cellular Pathology. [IF=0.751, Cited=3, 22407353].
Le Rhun A, Charpentier E (2012) Small RNAs in streptococci. RNA Biology. [IF=0.745, Cited=18, 22546939].
Chylinski K, Le Rhun A, Charpentier E (2013) The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA
Biology. [IF=0.745, Cited=195, 23563642].
Courtay A, Couturon I, Charpentier E, ..., Fery-Lemonnier E (2000) [Evolution of polyvalent intravenous immunoglobulins
(IVIg) prescription, at the Assistance Publique - Hopitaux de Paris between 1988 and 1997. Results of the plan of action
set up in order to regulate the prescription]. None. [IF=None, Cited=1, 10896982].
Barrasso R, Souques M, Charpentier E, ..., Zummer K (1990) [Control of laser treatment of 58 cervical condylomas: cyto-
colposcopic correlations at 3, 6 and 12 months]. None. [IF=None, Cited=0, 2173116].
Lugagne PM, Hiesse C, Bellamy J, ..., Benoit G (1990) [Autosomal dominant polycystic kidney in adults and
transplantation]. None. [IF=None, Cited=1, 2221829].
Charpentier C, Roux FX, Cioloca C, ..., Chodkiewicz JP (1986) [Management of cranial-injured patients in the era of the
Emergency Medical Service and the scanner. Comparative epidemiologic study with a 12-year interval in the same
department of neurosurgery, in the Paris region]. Neurochirurgie. [IF=0.969, Cited=0, 3822033].
Charpentier E (1984) [Hospital gowns]. Revue de l'Infirmiere. [IF=0.278, Cited=0, 6569654].
Roux C, Lemonnier E, Kolta S, ..., Viens-Bitker C (1993) [Ultrasound attenuation in calcaneus and bone density]. Revue
du Rhumatisme (Edition Francaise). [IF=0.041, Cited=3, 8012315].
Maccia C, Docou le Pointe H, Fery-Lemonnier E, ..., Viens-Bitker C (1996) [Photostimulation plates or conventional films
for bedside chest x-ray in pediatric radiology? A comparative study of quality of image and the dose delivered to
patients]. None. [IF=None, Cited=3, 9033870].